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Abstract
Francisella tularensis, the etiological agent of the inhalation tularemia, multiplies in a variety of cultured mammalian cells.
Nevertheless, evidence for its in vivo intracellular residence is less conclusive. Dendritic cells (DC) that are adapted for
engulfing bacteria and migration towards lymphatic organs could serve as potential targets for bacterial residence and
trafficking. Here, we focus on the in vivo interactions of F. tularensis with DC following airway infection of mice. Lethal
airway infection of mice with the live vaccine strain (LVS) results in trafficking of a CD11b
high/CD11c
med/autofluorescence
low
DC subset from the respiratory tract to the draining mediastinal lymph node (MdLN). Simultaneously, a rapid, massive
bacterial colonization of the MdLN occurs, characterized by large bacterial foci formation. Analysis of bacteria in the MdLN
revealed a major population of extracellular bacteria, which co-exists with a substantial fraction of intracellular bacteria. The
intracellular bacteria are viable and reside in cells sorted for DC marker expression. Moreover, in vivo vital staining
experiments indicate that most of these intracellular bacteria (,75%) reside in cells that have migrated from the airways to
the MdLN after infection. The correlation between DC and bacteria accumulation in the MdLN was further demonstrated by
manipulating DC migration to the MdLN through two independent pathways. Impairment of DC migration to the MdLN,
either by a sphingosine-1-phosphate receptor agonist (FTY720) or by the D prostanoid receptor 1 agonist (BW245C),
resulted in reduced bacterial colonization of MdLN. Moreover, BW245C treatment delayed the onset of morbidity and the
time to death of the infected mice. Taken together, these results suggest that DC can serve as an inhabitation niche for F.
tularensis in the early stages of infection, and that DC trafficking plays a role in pathogen dissemination. This underscores
the therapeutic potential of DC migration impairing drugs in tularemia treatment.
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Introduction
Dendritic cells (DC) are a heterogeneous group of antigen
presenting cells (APC), which reside in peripheral tissues, and serve
as sentinels for invading microorganisms. Most often, contact of
DC with microorganisms results in engulfment of the microor-
ganism, and triggers a series of programmed events (maturation).
These include surface expression of MHC class II and of co-
stimulatory molecules, induction of cytokine secretion, and
degradation of the internalized pathogen, allowing for surface-
presentation of its antigens to naı ¨ve T cells [1].
The encounter between DC and T cells is facilitated by the
induced trafficking of activated DC from the periphery to the
vicinal draining lymph nodes. The mechanisms that control DC
trafficking appear to be complex. Modulation of the surface
display of chemokine receptors (up regulation of CCR7 expression
and down regulation of other receptors) plays a key role in this
process [2,3,4]. In addition, other effectors including prostaglan-
dins [5] and sphingosine-1-phosphate [6] also play a critical role in
DC migration.
F. tularensis, the etiological agent of tularemia, is a zoonotic
pathogen with a broad host range. Disease manifestations depend
upon the route of infection and include ulceroglandular infection,
respiratory infection and a typhoidal disease [7]. The high
infectivity of certain F. tularensis strains via inhalation led to their
classification as a Category-A threat agent. Two subspecies of F.
tularensis, F. tularensis subsp. tularensis (type A) and F. tularensis subsp.
holoarctica (type B) are highly infectious to humans yet only the type
A bacterium is life-threatening [7,8]. Most research on the
pathogenesis of F. tularensis has been performed on mice using the
live vaccine strain (LVS) derived from F. tularensis subsp. holoarctica.
This organism shows attenuated virulence in humans but is lethal
to mice following pulmonary infection [9].
F. tularensis strains are capable of infecting and multiplying in a
variety of cultured cells (reviewed in [10]). The mechanisms used
by the pathogen to escape the phagocytic pathway and grow inside
cells have been the subject of intense research [11,12], and specific
proteins required for intra-macrophage growth were identified.
These include members of the iglABCD operon [13,14] and the
pdpA and pdpD genes contained within a Francisella pathogenicity
island (reviewed in [15,16]). In many cases mutant strains that are
impaired in intra-macrophage growth were also identified as
attenuated in murine infection models [12,17].
All this led to the accepted notion that intracellular growth is a
key mechanism used by F. tularensis to escape host defense.
Nevertheless, the direct body of evidence for intracellular growth
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by immunostaining in lungs of infected mice [18] and PCR
analyses suggest that practically all F. tularensis LVS organisms of
bacteremic mice are cell-associated [19]. Nevertheless, the
association between LVS and blood cells was recently contested
by showing that the majority of F. tularensis recovered from blood
of infected mice reside in the plasma [20]. Thus, in spite of the
increased efforts in this direction, the various manifestations of the
interaction of F. tularensis with host cells, and the role of these
interactions in tularemia pathogenesis are far from being resolved.
In the present study we have focused on the interactions of F.
tularensis LVS with DC in vivo. We show that airway infection by
LVS is followed by bacterial colonization of the mediastinal lymph
node (MdLN), which occurs in parallel to recruitment of
respiratory tract DC (RTDC) from the airways to this draining
lymph node. Moreover, administration of two different DC
migration inhibitors impairs bacteria accumulation in the MdLN,
and not less importantly, affects the course of disease. Finally, we
show that cells with characteristic DC phenotype that have
immigrated to the MdLN from the respiratory tract carry viable
intracellular F. tularensis.
Results
Pulsing of BMDC by LVS results in intracellular bacterial
propagations as well as induction of cell migration
Several aspects of bacteria/DC interactions can affect the
dynamics of dissemination in the infected host. Among the most
relevant ones are cell inhabitation by bacteria and the ability to
trigger DC trafficking. These two features were examined in an in
vitro LVS-infection system, using bone marrow DC (BMDC) as
target cells.
In accordance with a previous report [21] LVS was found to
replicate in BMDC as efficiently as in the macrophage-like
J774A.1 cells (Figure 1A). Pulsing of host cells with bacteria (even
at an MOI as high as 200) led to an inefficient cell uptake
(,5610
4 bacteria were taken up by 10
6 cells). Yet, once bacteria
are taken-up by J774A.1 cells or BMDC, intracellular propagation
appeared to be very efficient, resulting in increase of more than
two orders of magnitude within 24 hrs.
Induction of maturation responses by F. tularensis in APC was
examined previously, revealing complex interactions, involving
activating as well as inhibitory effects [21,22,23]. Acquisition of
migratory properties is one of the aspects of bacteria-triggered DC
maturation and could, in principal, be also subjected to inhibitory
effects by LVS. As a first step in examining the effect of LVS/DC
interactions on cell migration we have examined surface
expression of CCR7, a receptor involved in DC trafficking from
the periphery to lymph nodes [4,24]. Flow cytometry analysis of
pulsed BMDC revealed a notable increase of CCR7 display
(Figure 1B and 1C). As expected, LPS of E. coli, which served as
positive control, led to an effective CCR7 induction. Killed LVS
bacteria were also found to be effective, though to a lesser extent,
in inducing surface display of CCR7, attesting to the stimulatory
potential of LVS pathogen associated molecular patterns (PAMP).
Most importantly, live bacteria were as effective as killed bacteria
in promoting CCR7 display, arguing against potential abrogating
effects exerted by the live pathogen. This is in contrast to the effect
of LVS on other markers of DC activation such as TNF-a
secretion, where induction occurs with killed bacteria and is
abrogated by live bacteria (not shown). It is also interesting to note
that display of certain co-stimulatory surface molecules, such as
CD83 and CD40 is affected by the viability of LVS (Figure 1C).
However, display of other molecules (e.g., CD86) appears to be
efficient following pulsing by live as well as killed bacteria.
As an additional step in evaluating DC migratory properties, we
have used an in vitro transmembrane chemotaxis assay. BMDC
were exposed to various stimulants for 24 hrs and then allowed to
migrate through a nylon mesh towards the CCR7-ligand CCL19
(Figure 1D). As controls, we have used non-treated cells and cells
exposed to E. coli LPS. Pulsing DC with E. coli LPS led to effective
induction of migration towards CCL19 (6 folds increase over
background). Pulsing with LVS bacteria resulted also in induction
of cell migration (about 4.5 folds over background). Migration
appears to be, at least partly, CCR7-dependent since migration in
presence of CCL19 is higher than in its absence (Figure 1D).
Again, no differences were found between the effects of killed and
live bacteria, suggesting that LVS does not exert adverse effects on
DC movement induction.
Taken together, the in vitro analyses suggest that DC have the
potential to serve as replication niches, as well as transport vehicles
for LVS. This prompted us to examine these functions in vivo.
LVS colonization of lymph nodes following respiratory
infection of mice
The interrelationship between F. tularensis and DC in vivo was
examined by using a mouse model for respiratory tularemia. As a
first step, we have examined the kinetics of LVS dissemination
from the respiratory tract to host organs. Mice were infected by
intranasal administration of 10
5 CFU of LVS, which is equivalent
to ,100 LD50 (LD50=,1000 CFU, our results as well as those of
others [9]) leading to death within 5–6 days.
Intranasal administration of LVS resulted in robust proliferation
of the bacterium in the airways (Figure 2A), confirming earlier
reports [25,26]. Bacterial counts in lungs increased by at least
three orders of magnitude within 2 days and remained constant as
long as mice were alive (Figure 2A). As expected, immediately after
infection, bacteria were localized in the broncholaveolar lavage
fluid (BALF). In the following days bacterial counts in the lung
were divided equally between BALF and lung tissue, and during
the late days of infection the relative amount of BALF bacteria was
somewhat lower (Figure 2A).
Author Summary
The high infectivity of Francisella tularensis via inhalation led
to its classification as a Category-A bio-threat agent and
renewedtheinterestinthispathogen. Here,wecharacterize
early events in respiratory tularemia, which could be
instrumental in designing new therapeutic approaches.
We focus on the interaction of F. tularensis with dendritic
cells, which serve as first-line sentinels for invading bacteria
and are expected to be pivotal in initiation of host
protective response. In this study, we show that lethal
airway infection of mice with F. tularensis results in
accumulation of both bacteria and dendritic cells in the
draining lymph node, and that viable bacteria can be
detected in dendritic cells that have been recently imported
from the airways. The correlation between trafficking of
dendritic cell and bacteria is further substantiated by
demonstrating that impairment of dendritic cell migration
to the draining lymph node through two independent
pathways results in decreased bacterial accumulation in the
lymph node. Taken together, our observations suggest that
F. tularensis actually harnesses dendritic cells to facilitate
bacterial dissemination and to enhancehost invasion.These
findings call for examination of the therapeutic potential of
drugs that impair dendritic cell migration as countermea-
sures for tularemia.
Trafficking DC and F. tularensis to Lymph Nodes
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24 hrs pot infection revealed viable bacteria, at levels as high as
10
4 CFU/MdLN (Figure 2A). This number increased to about 10
6
CFU/MdLN on the second day and then remained unchanged.
The accumulation of bacteria in the spleen and liver lagged behind
their accumulation in the MdLN. Levels comparable to those
found in MdLN at 24 hrs were reached in these organs 48 hrs post
infection (Figure 2A).
Taken together, these results underline the role of the draining
lymph nodes in respiratory LVS infection. MdLN colonization
begins very early post airway infection. It occurs immediately after
colonization in the primary infection site (lung), and precedes the
spreading of the pathogen to distant organs such as spleen and liver
(Figure 2A). The rate of LVS accumulation in the lymph node is
very rapid, close to two orders of magnitude within 24 hours,
resembling LVS propagation in tissue cultures at optimized
conditions (compare Figure 1A and Figure 2A). It is interesting to
note that the maximal number of organ-associated bacteria in
MdLN is 10
6 CFU/organ, compared to 10
7CFU/organ in spleens
and livers, which are about 100 folds larger in size.
To better characterize the robust colonization of the draining
lymph nodes by LVS, we searched by light microscopy for
bacterial localization in cryo-sections of MdLNs 72 hrs post
airway infection. This led to identification of distinct bacteria-
containing infection foci in LVS infected MdLNs. Most notable
are rare (1–2 per cross section), yet very expanded foci carrying a
large number of bacteria (Figure 2B). The average number of LVS
per cross section of such a focus was found to be 100–200 (such
large clusters could not be revealed 24 hrs post infection). Simple
geometrical calculations suggest the presence of more than 10
3
bacteria per one global focus. This morphological feature implies
an in-situ clonal expansion of bacteria that have entered the lymph
node at an early stage. Thus, bacterial accumulation in the MdLN
is not a mere reflection of bacterial influx from other organs. It
should be noted that at the same time point (72 hrs post infection),
one could find also much smaller foci (not shown) that could have
been formed by bacteria entering the MdLN at a later stage.
Taken together, our observations suggest that colonization of
the draining lymph node is a major step in bacterial dissemination,
following airway infection with LVS.
LVS infection triggers recruitment of DC to the
mediastinal lymph node
Once the kinetics of bacterial spreading was defined, we have
examined the cellular events related to respiratory infection of
mice by LVS. We have focused on phagocytic cells of the
monocytic lineage, and restricted the study to the early infection
sites: the respiratory tract and the MdLN.
In general, the respiratory tract monocytic phagocytes can be
defined by surface display of two markers, CD11c and CD11b
[4,27] and can be differentiated into alveolar macrophages and
pulmonary DC by virtue of their autofluorescence (AF) level.
Macrophages are defined by high AF, whereas pulmonary DC
exhibit low AF [28].
Analysis of single cell suspensions derived from the MdLN, two
days post intranasal infection revealed the presence of cells that are
CD11c
med/CD11b
high (Figure 3A, top), of cells that are
CD11c
med/AF
low (Figure 3A, center), as well as of cells that are
CD11b
high/AF
low (Figure 3A, bottom). These three populations
Figure 1. Interaction of BMDC and LVS in vitro Alter. (A)
Propagation of LVS in J774A.1 cells and BMDC: Infection was performed
as described in the Materials and Methods section, and gentamicin was
added 1 hr post pulsing with bacteria. Cells were harvested 2 or 24 hrs
post infection, washed, and lysed with DOC. Lysates were diluted and
plated for CFU enumeration. Each bar represents the average CFUs in
three infection wells. The entire experiment represents one of three
repetitions. For visualization of cell-associated bacteria by fluorescence
microscopy, infected J774A.1 or BMDC cells were stained with anti-LVS
antibodies 24 hrs post LVS infection. (B) Expression of CCR7 by BMDC:
Cells were analyzed for CCR7 expression 24 hours post infection with
the live or formaldehyde-killed LVS. Non-pulsed cells and cells pulsed
with 1 mg/ml E. coli LPS served as negative and positive controls,
respectively. Gray lines denote isotype-matched immunoglobulin
controls. Fractions of CCR7
positive cells are indicated. (C) DC were pulsed
as indicated above, and expression of co-stimulatory molecules was
examined as described in Materials and Methods. Geomeans of
fluorescence intensities are presented as relative values, using the
values obtained for each marker by pulsing with 1 mg/ml E. coli LPS as
100. Results are presented by bar diagrams as the averages of three
independent experiments. (D) Migration of BMDC: Cells were pulsed as
indicated above, 24 hrs later cells were examined for migration in
Transwell chambers towards CCL19 or control medium. Non-pulsed
cells and cells pulsed with LPS served as controls. Results are presented
as percent cells migrating from the upper compartments to the lower
compartment. Each bar represents the average migration in 3
Transwells. The experiment was repeated 3 times. Data presented in
this figure were generated by using BALB/c BMDC. Results were
confirmed with DC derived from C57BL6 mice.
doi:10.1371/journal.ppat.1000211.g001
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presence of a CD11c
med/CD11b
high/AF
low cell population in the
MdLN. The appearance of such cells in the MdLN is infection-
dependent, since background levels of this population are ,10
times lower in non-infected animals (Figure 3A, left panels), as well
as in mock infected mice (PBS instillation, not shown).
The phenotype of the CD11c
med/CD11b
high/AF
low cell
identified in the MdLN matches accurately the phenotype of an
Figure 2. Spreading of LVS in intranasally infected mice. Mice were infected intra-nasally with 10
5 CFU of LVS. (A) Bacteria were counted in
BALF, lung tissue after lavage, MdLNs, spleens, and livers in animals sacrificed at the indicated time points after infection. Single cell suspensions
derived from the various organs were diluted in PBS and plated for CFU counts. Each bar represents the average counts in 3 individual animals.
Experiment was repeated 2 more times, resulting in similar observations. (B) Microscopy evaluation of MdLN colonization was performed on cryo-
sections of MdLN, 72 hrs post infection with LVS. Sections were stained with rabbit anti-LVS hyperimmune serum and FITC-conjugated secondary
antibody. One representative large infection focus is shown.
doi:10.1371/journal.ppat.1000211.g002
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vs. AF is shown in Figure 3B). The appearance of this population
in the lung is not dependent on infection.
Analysis of cells derived from the BALF revealed this same
population, but also revealed a distinct population of CD11b
med/
AF
high cells (Figure 3C) which happens to be also CD11c
high (not
shown). The phenotype of these CD11c
high/CD11b
med/AF
high
cells and their presence in the BALF prompted us to define them
as alveolar macrophages (AMW). The CD11c
med/CD11b
high/
AF
low population, on the other hand, was defined as a subset of
respiratory tract DC (RTDC), relying on previous characteriza-
tions of such populations [4,28]. The definition of these cells as
DC is further supported by surface expression of MHC class II
(not shown).
The kinetics of RTDC recruitment to the MdLN following
infection with 10
5 CFU of LVS is marked by a burst in cell influx
on day 2 (Figure 4) reaching levels close to 10
5 RTDC per lymph
node. This is followed by a decline at later days. The
representation of RTDC cells on the first day post infection with
10
5 CFU was not higher than background levels measured in non-
infected mice (Figure 4). Nevertheless, when infection dose was
increased from 10
5 to 10
7 CFU, one could clearly detect
recruitments of RTDC, as early as 24 hours post infection (not
shown).
In order to define the origin of the DC imported to the MdLN,
we have labeled the respiratory tract cells by vital staining [29].
The orange cell tracer CMTMR was administered to mice by
intranasal instillation, five hours prior to intranasal infection by
LVS. MdLN cells were isolated on the next day, and examined for
presence of CMTMR and for DC-marker expression. In this
protocol we have used an infection dose of 10
7 CFU, which
allowed early monitoring of cell trafficking. Flow cytometry
analysis revealed MdLN cells carying CMTMR, which also
express CD11c (Figure 5A and 5B). One such cell population
which is CMTMR
+/CD11c
med exhibits a ,4 fold increase
following infection, indicating migration of CD11c
med cells from
the respiratory tract to the draining lymph node (Figure 5A and
5B). This migration is substantiated by another set of experiments
indicating that the CD11c
med cells accumulating in the infected
MdLN display on their surface CCR7 (not shown).
Figure 3. Definition of cell phenotypes in infected lungs and MdLNs. Single cell suspensions of MdLN (A), washed lung (B), and BALF (C)
were prepared from organs collected 48 hrs post infection with 10
5 CFU of LVS. Cells derived from non-infected animals served as controls. MdLN and
BALF cell suspensions were stained for expression of CD11c and CD11b using antibodies conjugated to APC or PE, and analyzed by flow cytometry
for surface display of markers as well as autofluorescence at FL1. Data are presented in the form of dot diagrams using parallel gating for
identification of infection-triggered recruitments (numbers indicate percentage representations of the gated populations). Isotype-matched
antibodies served as controls, and the same gates used in specific stain analysis were evaluated. In this case, gated population frequencies in infected
organs were comparable to backgrounds (not shown). All analyses presented were conducted on tissues pooled from 3 individual animals. Three
independent experiments exhibited similar cell profiles.
doi:10.1371/journal.ppat.1000211.g003
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fractionated MdLN cells by magnetic sorting (MACS), using
beads coated with anti-CD11b antibodies. Bound and non-bound
cell fractions were then analyzed for presence of CMTMR and for
surface display of CD11b or CD11c (Figure 5C–5F). Sorting by
anti CD11b-coated beads resulted in the expected enrichment for
cells expressing CD11b but at the same time in enrichment for
cells stained by CMTMR (Figure 5C). Actually 27% of the cells in
the CD11b-sorted population were highly positive for both
CMTMR and CD11b, as opposed to ,2% in the non-bound
fraction (Compare Figure 5C and 5E). Sorting by CD11b also
resulted in a comparable enrichment for cells that were CD11c
positive (Figure 5D and 5F), leading to 23% representation of
CMTMR
+/CD11c
+ cells (Figure 5D). Moreover, closer examina-
tion of the sorted cells reveals a correlation between high uptake of
the viable dye and intermediate expression of CD11c.
The viable staining experiments provide indication to the
trafficking of cells expressing both CD11c and CD11b from the
respiratory tract to the draining lymph node in the infected
animal. This result together with the observed accumulation of
RTDC in the infected MdLNs attests to an LVS-induced
trafficking of DC in vivo.
Association of LVS with CD11c/CD11b cells within
mediastinal lymph nodes
The in vivo trafficking of both viable LVS (Figure 2) and of DC
to the MdLN (Figure 5) as well as the in vitro infection results
(Figure 1), led us to search for association between host cells and
LVS in the infected lymph node.
As a first step in evaluating the localization of bacteria in the
MdLN cells, we have subjected single-cell suspensions, obtained
48 hours post intranasal infection, to a gentamicin protection test.
About 10% of the bacteria found in the cell suspensions survived
gentamicin treatment (Figure 6A), suggesting that this bacterial
population is localized within cells and is therefore not accessible
to the antibiotic. The other approach used to identify cell-
associated bacteria was based on differential centrifugation and
provided similar results. Mild spinning (200 g, 10 min) resulted in
a supernatant containing ,90% of the MdLN bacteria and a cell
pellet containing ,10% of the bacterial content (Figure 6A).
To characterize the cells that carry LVS, we have subjected
washed MdLN cell suspensions to magnetic cell sorting by beads
conjugated to anti-CD11b antibodies (Figure 6B, top panel).
Fractionated cells were then analyzed for association with LVS.
The amount of viable bacteria, per a given number of anti-CD11b
bound cells was found to be 1000 folds higher than that in the
unbound fraction (Figure 6B, top). Moreover, the actual amount of
bacteria in the unbound fraction is in good agreement with the
residual amount of ,0.5% CD11b
+ cells found in this fraction
(data not shown). Altogether this suggests a specific association
between LVS and CD11b
+ cells in the infected lymph node.
Flow cytometry analysis of the CD11b-MACS sorted cells
revealed that, as expected (Figure 3 and Figure 5), bound cells
display on their surface CD11c in addition to CD11b. This led us
Figure 5. Identification of cells immigrating from airways to the
MdLN by in vivo viable staining. Airway cells of live mice were
stained by instillation of CMTMR. Migration to lymph node was induced
by intranasal infection with 10
7 CFU of LVS, using PBS instillation as
control. Single cell suspensions were prepared from a pool of 8 lymph
nodes collected 18 hrs post infection. Cells were analyzed by flow
cytometry prior to (top panel, A and B) or after sorting by MACS with
CD11b-microbeads (lower panel, C–F). Cells were stained with either
APC-conjugated anti-CD11c (A,B,D,F) or APC conjugated anti-CD11b
(C,E). Surface marker staining was plotted against CMTMR staining. Data
are presented as dot diagrams. Gating for CMTMR staining and marker
staining was based on diagrams of the appropriate non-stained
controls (not shown). Numbers indicate cell percentage of the gated
populations or of that defined by quadrants. Similar results were
obtained in two other similar experiments.
doi:10.1371/journal.ppat.1000211.g005
Figure 4. Cell recruitment to MdLN following airway infection
with LVS. MdLNs were isolated at various time points after intra-nasal
infection of mice. Single cell suspensions were analyzed by flow
cytometry as indicated on the legend to Figure 3. Number of AMW and
RTDC at different time points post infection are presented as bar
diagrams.
doi:10.1371/journal.ppat.1000211.g004
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(Figure 6B, bottom panel). Results of this fractionation were very
similar to those obtained by CD11b MACS sorting (compare top
and bottom panels of Figure 6B). The amount of viable bacteria,
per a given number of anti-CD11c bound cells was found to be
,500 folds higher than that in the unbound fraction (Figure 6B,
bottom). Thus, LVS appears to associate with CD11b
+ as well as
CD11c
+ cells.
In order to determine if the observed bacteria/cell association
reflects intracellular residence of LVS, CD11b sorted cells from
infected MdLNs were subjected to gentamicin protection tests
(Figure 6C). The number of viable bacteria was not affected by
pretreatment with gentamicin, indicating that LVS indeed resides
inside CD11b
+ cells. Moreover, when gentamicin-treated cells were
lysed with saponin, the number of measurable viable counts was
higher by ,4 folds, indicating presence of several bacteria within one
cell. As expected, lysis of cells prior to antibiotic treatment, relieved
cell protection, and rendered all bacteria sensitive to gentamicin.
To substantiate the intracellular localization of bacteria in DC of
infected lymph nodes, the CD11b sorted cells, as well as CDb11c
Figure 6. Association of LVS with a specific cell population in infected lymph nodes. Mice were infected intra-nasally with 10
5 CFU of LVS.
Forty-eight hours later MdLNs were collected from 10 animals and single cell suspensions were prepared and examined by several assays. (A)
Association between viable bacteria and MdLN cells was assayed by examining non-washed (total LN suspension) and washed cells for presence of
viable LVS prior or post gentamicin treatment. Bacterial counts are presented as CFU per a single MdLN. (B) Association between LVS and RTDC cells
was assayed by subjecting the washed cell fraction (,10
8 cells) to sorting by magnetic microbeads coated with either anti-CD11b (B, top panel) or
anti-CD11c (B, lower panel). Viable bacteria (no gentamicin treatment) were counted in the input cell suspension, in the bound cell fraction, as well as
in cells that did not bind to the microbeads, and presented as CFU/10
6 cells. The amounts of cells in the input and in the bound fractions were ,10
8/
10 MdLNs and in the bound fractions only ,10
6/10 MdLNs. CD11b and CD11c sorted cells were also examined by fluorescence microscopy for
presence of intracellular bacteria. Typical cells carrying bacteria are presented in the insets to (B). (C) The cell/bacteria association in the CD11b-sorted
fraction was characterized by determining bacterial count in non-treated cells, in cells treated with gentamicin (genta), in cells treated with
gentamicin followed by washing and saponin lysis (genta+sap), as well as in cells where saponin treatment preceded gentamicin treatment
(sap+genta). All bacterial counts were performed in triplicates, error bars represent variation of these counts. Data presented in this figure were
collected from a single experiment. Two additional CD11b sorting experiments and one additional CD11c sorting experiment were conducted,
exhibiting similar enrichment of intracellular bacteria.
doi:10.1371/journal.ppat.1000211.g006
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analysis revealed cells carrying LVS (Figure 6B, insets). These cells
were not very abundant; nevertheless, in almost all cases more than
one bacterium was associated with a single cell.
Taken together, the results presented in Figure 6 reveal that
viable LVS bacteria reside within MdLN cells that exhibit an
RTDC phenotype.
Association of LVS with newly immigrating cells within
the MdLN
To examine the origin of the CD11b-sorted, LVS-carrying cells,
we have resorted to in vivo vital staining. Cells lining the
respiratory tract were stained with CMTMR, as described above
(Figure 5), animals were sacrificed 2 days later, and single cell
suspensions derived from the infected MdLNs were first subjected
to flow cytometric analysis (Figure 7A). The bound fraction
contained, as expected, a substantial amount of fluorescent cells,
about 20% of which exhibited fluorescence levels higher then
background autofluorescence. These and were therefore defined as
CMTMR stained cells (Figure 7A). Only trace amounts of this
population were present in the non-bound fraction.
Sorted cells were mounted on chamber slides, and were screened
by fluorescence microscopy for the presence of the intracellular
orange CMTMR staining, as well as presence of cell-associated
bacteria. This resulted in identification of CMTMR
+/LVS
+ cells,
CMTMR
+/LVS
2 cells, and CMTMR
2/LVS
+ cells (representative
cells are shown in Figure 7B). The relative distribution of these cell
types (Figure 7C) revealed a strong linkage between CMTMR
stainingand presence of intracellular bacteria. Screening of1000 cells
which were not bound to CD11b, failed to reveal any CMTMR
+
cells, and revealed only two CMTMR
2 LVS-carrying cells.
Screening of 2200 CD11b-bound cells revealed 220 cells that carried
CMTMR at levels sufficient to allow microscopic detection. Of these
CMTMR
+ cells, as much as 38% were found to carry bacteria. In
contrast, only 2.5% of the CD11b-bound cells, which were not
stained by CMTMR were found to carry bacteria (Figure 7C).
To further define the intra-cellular residence of LVS, we
counted the number of bacteria in the individual cells. The
average number of bacteria in the CMTMR
+ cells was found to be
Figure 7. Association of LVS with newly immigrating cells in infected lymph nodes. Airway cells of live mice were stained by instillation of
CMTMR. Migration to lymph node was induced by intranasal infection with 10
5 CFU of LVS. Single cell suspensions were prepared from pools of 8
lymph nodes, collected 48 hrs post infection. Cells were sorted by MACS with CD11b-microbeads. Bound and non bound cells were analyzed by flow
cytometry (A) to evaluate the fraction of CMTMR
+/CD11b
+ cells. Sorted cells were examined by florescence microscopy for presence of the indicated
cell phenotype (B). Large numbers of cells were screened to determine the proportion of the various cell populations (C). In addition, the average
number of bacteria per cell in LVS-bearing CMTMR
+ and CMTMR
2 cells was determined (C, last column).
doi:10.1371/journal.ppat.1000211.g007
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2 cells 2.861.9. When the total
number of bacteria residing in these two cell populations is
calculated (440 in CMTMR
+ cells and 140 in CMTMR
2 cells), it
becomes evident that as much as 75% of the bacteria associated
with CD11b-sorted cells reside within newly imported cells.
While the actual number of bacteria per cell in the CMTMR
2
population does not seem to be very different from that in the
CMTMR
+ population (2.8 vs 5.2), the statistical significance of the
difference is very impressive (P,10
25, Figure 7C). This implies
that the events leading to bacterial residence in these two cell
populations are different.
Taken together, these results attest to preferential bacterial
residence in cells that have recently immigrated from the airways
to the MdLN. These results also imply that two cell-infection
mechanisms take place during airway infection; one occurs in the
airway at the early stages of infection, and the other occurring later
on, either in the airways or in the lymph node.
Treatment with the S1P homologue FTY720 results in
impairment of DC migration and of MdLN colonization
The residence of intracellular bacteria in RTDC, and more
specifically in newly-immigrated MdLN cells suggests that DC
play a role in F. tularensis trafficking. To further examine this point,
the effect of RTDC migration-impairment on bacterial dissemi-
nation was tested using FTY720 (fingolimod), a sphingosine
analogue. FTY720 counteracts the functions of the sphingosine-1-
phosphate (S1P), and thereby impairs cell migration [30]. FTY720
inhibits lymphocyte egress from lymphoid tissue, and was also
found to inhibit migration of lung DC to the MdLN [6].
FTY720 in its carrier solution, or carrier solution alone were
administered intranasally to mice, concomitantly to infection.
MdLNs were analyzed two days later by flow cytometry. The
MdLN of infected, mock-treated, animals carried the distinct
CD11b
high/autofluorescence
low cell population (Figure 8A), which
defines RTDC recruitment (Figure 3). In mice treated with
FTY720, this population was brought down to background levels
(Figure 8B and 8C), indicating that FTY720 impairs very
effectively the LVS-triggered RTDC migration to the MdLN.
The FTY720 treatment resulted also in a substantial reduction in
the LVS counts in the MdLN (Figure 8D). Mock-treated mice
carried 1.3610
660.9610
6 live LVS in the MdLN. This number
was reduced by two orders of magnitude in FTY720 treated mice,
reaching values of 1.1610
460.5610
4. Thus, administration of a
S1P analogue to the airways of LVS infected mice impairs
effectively recruitment of RTDC to the MdLN, as well as
colonization of this organ, implying that these two events are linked.
Impairment of DC trafficking by the prostaglandin
analogue BWC245C affects MdLN colonization by LVS
and disease progression
To substantiate the observed correlation between DC and LVS
trafficking, we examined the effects of an additional inhibitor of
DC-migration, which is known to act through a different
mechanism. We have chosen BW245C, a D prostanoid receptor
1 (DP1) agonist, known to inhibit in vivo migration of Langerhans
cells [31,32] as well as airway DC [5].
BW245C was administered by two intranasal instillations, one
immediately prior to LVS inoculation, and the other 24 hours
later. The effect of agonist administration on recruitment of DC
and bacteria to the MdLN was examined 48 hours post infection.
The BW245C treatment resulted in a marked reduction in the
representation of RTDC in the infected lymph node (Figure 9A).
While ,7610
4 of the MdLN cells exhibited the RTDC phenotype
in LVS infected mice, DC representation in infected mice, treated
with BW245C was reduced to ,2610
4. It should be noted that
background levels in non-infected mice, either treated or not
treated with the agonist, remained ,0.6610
4.
The effect of BW245C on the infection-dependent DC
recruitment was accompanied by a significant impairment of
MdLN colonization by LVS (Figure 9B). The average number of
viable bacteria in the draining lymph nodes 48 hours post airway
infection was 480.0006180.000. This number was reduced to
75.000621.000 upon treatment with BW245C. It should be noted
that treatment had no effect on the number of bacteria or of DC in
the lung, excluding possible bacteriostatic/bacteriocidic or cyto-
toxic effects of the drug in vivo. Taken together, these results
provide additional evidence to the linkage between the accumu-
lation of RTDC and of viable bacteria in the draining lymph
nodes following infection.
To examine the effect of the DP1 agonist on the course of
experimental respiratory tularemia, infected mice were subjected to
a short treatment by intranasal instillation of BW245C as described
above. Animals were monitored for survival in comparison to
infected, sham-treated (instillation of carrier only) animals. Results
presented in Figure 9C indicate that the short treatment (day 0 and
day 1) resulted in a delay of one day in the time to death of mice.
Mean time to death without treatment was 6.4, as compared to 7.5
following treatment. This difference appears to result from a
treatment-dependent delay in the onset of the disease manifesta-
tions. Monitoring of animal morbidity revealed significant differ-
ences (Figure 9D) in the kinetics of weight loss in treated vs. non-
treatedmice.Thefirstdayismarkedbya moderateweightlossinall
animals, which stems from the instillation procedure itself, as the
same loss is also observed in treated non-infected mice. Nevertheless
the disease-induced weight loss starts after day 1 in infected non-
treated animals and after day 2–3 in treated animal (Figure 9D).
Similar experiments, conducted with FTY720 were marred by the
intrinsic long-term pleotropic effects of this agonist on lymphocyte
mobilization[30].AsingleFTY720instillationinto infectedanimals
resulted in a somewhat prolonged mean time to death, but did not
alleviate weight loss (not shown).
In summary, treatment with a DP 1 agonist, like treatment with
an S1P analogue has a marked effect on DC recruitment to the
draining lymph node and on bacterial colonization of the lymph
node. This treatment also delays the time point at which disease
becomes apparent, and the time of death of the infected animals.
Discussion
DC play a key role in surveillance for pathogen invasion through
skin and mucosal epithelium. DC are highly adapted for sampling,
killing and processing microbes, and for trafficking the processed
material to regional lymph nodes for antigen presentation.
Impairment of certain DC functions by pathogens has been
addressed by numerous studies during the last years (reviewed in
[33]), yet much less is known about the specific interplay between
DC migration and microbial infection. One can envision two ways
by which manipulation of DC migration could enhance microbial
invasiveness. DC/pathogen interaction could impair DC migra-
tion to the draining lymph node [34,35], and thereby interfere
with the onset of immune responses. Alternatively, hijacking of the
DC migration process by intracellular pathogens and its
adaptation for dissemination of live microbes [36,37] could
provide an advantageous mechanism for subverting the immune
system, and at the same time facilitate the progress of infection.
In the present study we examined the dynamics of DC
trafficking in mice infected with F. tularensis LVS. It is widely
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TLR-mediated induction of surface display of the chemokine
receptor CCR7. The ability of live LVS to trigger this process is
not self-evident. LVS carries on its surface an atypical LPS which
is limited in its capacity to interact with cellular TLRs [38,39,40],
and could therefore be handicapped in triggering signal transu-
dation involved in cell trafficking. Moreover, LVS can actively
abrogate activation processes within immune cells, as indicated by
the observed effect of live LVS on expression of certain co-
stimulatory DC markers (Figure 1C), as well as on expression of
pro-inflammatory cytokines (our unpublished results and those of
others [22,23]). In spite of all this, pulsing of BMDC in vitro with
LVS resulted in induction of notable, surface expression of
functional CCR7 (Figure 1B and 1D).
To examine manifestations of these migratory properties in vivo,
a mouse model based on airway infection of mice by LVS was
employed, and migration of DC from the infection site to the
draining lymph node was analysed. Identification of such DC is
complicated bytheuniquefeaturesofrespiratorytract APC.Several
populations of monocytic phagocytes were identified in the different
anatomical compartments of lung [27,41], and moreover, APC in
the pulmonary tract exhibit unusual phenotypes. On one hand,
CD11b which is considered to be a typical marker for macrophages,
is low in alveolar macrophages yet appears on certain pulmonary
DC. On the other hand, CD11c which is routinely used as marker
to identify DC in peripheral lymphoid organs is also present on
pulmonary macrophages (reviewed in [42,43,44] ).
In an attempt to define RTDC populations affected by LVS we
have examined lungs of infected mice for expression of CD11c and
CD11b and identified two major integrin-expressing populations.
One population that is present only in the BALF is characterized
by high expression of CD11c, low expression of CD11b and high
autofluorescence (Figure 3B) and thus exhibits the characteristics
of alveolar macrophages. The other major population can be
Figure 8. The effects of FTY720 on accumulation of RTDC and LVS in the MdLN. Mice infected with 10
5 LVS were treated with FTY720
diluted in carrier solution, or with carrier solution alone, as described in Materials and Methods. To examine DC trafficking, MdLNs were collected
48 hrs post infection and analyzed for RTDC representation (CD11b
high/autofluorescence
low) as described in the legend to Figure 3. An experiment
was conducted on MdLN pools, each consisting of 6 organs. MdLNs were derived from infected mice treated with either carrier alone (A) or with
FTY720 (B). Non-infected, FTY720-treated mice (C) served as controls. Bacterial colonization of the MdLN (D) was examined 48 hrs post infection in
each one of the 6 individual FTY720- treated and 6 mock-treated mice, P,0.01. Three independent experiments, each conducted with groups of six
mice, exhibited similar correlation between RTDC and LVS recruitment.
doi:10.1371/journal.ppat.1000211.g008
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autofluorescence [28,45], high CD11b expression [4,46,47],
intermediate level of CD11c [48,49] and also high surface
expression of MHC class II (not shown) [50].
The phenotypic definition of the relevant cell populations
(Figure 3), prompted us to search for cell trafficking to the MdLN.
This led to the identification (Figure 4) of infection-dependent
recruitment of RTDC to the draining lymph node, with no
apparent recruitment of AMW. Moreover, our experiments suggest
that cells have been imported from the infected respiratory tract.
The phenotype of the cells matches accurately the phenotype of
DC identified in lung tissue and BALF (Figure 3), and cells were
shown to carry a vital dye (CMTMR), instilled into the respiratory
tract prior to infection (Figure 5).
Taken together our findings indicate that in vivo interactions
between F. tularensis and DC can induce the signaling process
leading to cell migration from the infection site to the draining
lymph node. This observation substantiates the prevailing notion
Figure 9. The effects of BW245C on the outcome of LVS infection. Mice infected with 10
5 LVS were treated with BW245 diluted in carrier, or
with carrier alone, as described in Materials and Methods. To examine DC trafficking (A), MdLNs were collected 48 hrs post infection and analyzed for
RTDC representation (CD11b
high/autofluorescence
low). Experiments were conducted on MdLN pools, each consisting of 6 organs, derived from
infected or non-infected mice treated with either BW245C or carrier alone. Results are presented by bar diagrams as the averages of three
independent experiments. * P,0.05. Bacterial colonization of the MdLN (B) was examined 48 hrs post infection in 13 individual BW245C-treated and
13 mock-treated mice. ** P,0.05. The effect of BW245 on mortality (C) was examined in groups of 10 mice comparing treated (open squares) and
mock-treated mice (closed circles). The experiment presented represents one of three similar experiments. The effect of the drug on morbidity (D)
was examined by monitoring weight loss for 5 consecutive days in groups of 10 mice each (8-week-old females). Groups consisted of non-infected
BW245-treated mice (closed triangles), infected and treated mice (open squares), and infected mock-treated mice (closed circles). Data are presented
as percentage of the weight determined on day zero and calculated separately for each individual mouse. *** P-values on days 2–5 range between
,0.01 and ,0.05.
doi:10.1371/journal.ppat.1000211.g009
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following invasion of the airways. We show that such a migration is
induced not only by soluble antigens [50] and inert particles and
spores [4,51], but also by viable respiratory pathogens. Moreover,
the DC that take part in this process are identified as a specific
subset of CD11c
med/CD11b
high RTDC. The CD11b
high DC-
subset was recently distinguished functionally from the CD11b
low
subset, and was associated with directing leukocyte trafficking
during lung inflammation [37,46,52].
Another part of this study was dedicated to bacterial spreading
following airway infection with LVS (Figure 2A). We show that
infiltration of MdLN by bacteria is a very early event (occurring
during the first day of infection), resulting in a massive load of
bacteria accumulating in the lymph node, at a very high rate
(Figure 2A). These results, which characterize infection by LVS as
well as by the Schu4 strain [22] suggest that colonization of
draining lymph nodes is an important stage in bacterial spreading.
Moreover, microscopic analysis of MdLN from LVS infected mice
at the late stages of infection reveal large foci of infection carrying
tens of bacteria, suggesting in situ replication of a clonal nature, i.e.
single bacteria infiltrating the tissue at early stages have replicated
in the lymph node to generate a large condensed focus. All this
underlines the major role played by tropism for lymphatic organs
in F. tularensis pathogenesis.
It is tempting to speculate that the invading bacteria are carried
into the MdLN by immigrating RTDC. The rate of bacterial
spreading from the infected airways actually supports such a
model. Bacteria can be detected in MdLNs at substantial amounts,
as early as 24 hrs post infection, and this correlates well with short
time frames reported for transport of soluble or particulate antigen
from the airways to the draining lymph nodes in mice
[4,50,51,53]. Nevertheless, comparison of the kinetics of bacterial
inhabitation of the MdLN to those of DC recruitment reveals that
bacteria are detected in the lymph node at least one day prior to a
notable increase in DC numbers (compare results of infection with
10
5CFU in Figure 2A and Figure 4). One should note, however,
that the sensitivity of detecting bacterial import is much higher
than that for detecting DC import. One can easily detect the
presence of several CFU in the MdLN, whereas detection of newly
immigrating DC over a background of ,1% representation is
difficult (Figure 3A and Figure 4). Actually, one cannot preclude
the possibility that LVS infection triggered the immigration of
,10
3 DC (,10% of the observed background) on the first day of
infection and that these cells are instrumental in spreading the
infection. Indeed when intranasal infection dose was increased
from 10
5 to 10
7 CFU newly immigrating DC were identified
24 hrs post infection (Figure 5), indicating that early recruitment
does occur, and suggesting that the extent of recruitment is
dependent on the bacterial load in the respiratory tract.
As a first step in defining the correlation between LVS and DC
accumulation in the draining lymph node, we have identified
intracellular inhabitation of LVS in MdLN cells. LVS-carrying
cells could be enriched by magnetic sorting for expression of
CD11c as well as CD11b. The similar efficiency of the two sorting
processes (Figure 6B and 6C) in retrieving cell-associated bacteria
suggests that LVS-containing cells express CD11c as well as
CD11b on the same cell. CD11c and CD11b expression, which
characterizes monocytic phagocytes is not exclusive to DC, yet
presence of such cells in MdLNs following airway infection would
argue for their definition as RTDC [4]. The cell-associated
bacteria were found to be viable, as indicated by their ability to
form colonies and are located within the cells, as indicated by their
resistance to antibiotics (Figure 6C). These observations provide
one of the more solid indications to the localization of live F.
tularensis in cells of the infected host, and identify the RTDC as an
in vivo niche for pathogen residence. The fact that most cells carry
several intracellular bacteria probably reflects intracellular repli-
cation of LVS, rather than simultaneous uptake of several bacteria
by an individual cell.
While MdLN DC appear to carry LVS, one cannot overlook
the presence of a large extracellular bacterial load in the infected
MdLN (Figure 6A). This finding underlines the long and
unresolved debate on the interrelationship between the intracel-
lular and the extracellular life styles of F. tularensis, and their
relevance to pathogenesis. While extracellular bacterial trafficking
per se cannot be excluded, one can envision an infection
mechanism that involves uptake of LVS by DC in the airways
[18,21] and import of bacteria-harboring DC into the MdLN
followed by apoptosis-mediated (our unpublished results and those
of others [14]) release of bacteria from the cells. Such a model
would imply an initial stage of intra-DC residence required to
overcome early host defense mechanisms, which is then followed
by an extracellular colonization process, and possibly re-infection
of more cells
A major support for the function of RTDC as transporters of
LVS comes from the in vivo viable staining experiments (Figure 7).
Staining of infected airway cells with CMTMR allowed us to
determine that a major fraction of the CD11b-sorted, LVS-
carrying cells are newly-immigrating cells, recruited from the
respiratory tract to the MdLN after infection (Figure 7). Moreover
enumeration of intracellular bacteria revealed that the about 75%
of the bacteria carried by CD11b-sorted cells actually reside in the
newly-immigrated cells.
The preferential presence of intracellular LVS in newly-
immigrating RTDC (Figure 7C) provides very strong support to
DC-mediated, LVS trafficking. In order to address the less-likely
possibility of preference in LVS uptake by the newly-immigrating
within the MdLN, we have treated mice with inhibitors of DC
migration. Trafficking of DC from the infection site is governed by
a variety of mechanisms. The most characterized mechanisms
relate to controlled change of the surface-displayed chemokine
receptors repertoires. Other mechanisms involve sphingosine-1-
phosphate [6,54], scavenger receptor A [55], osteopontin [56] and
prostaglandins [5,42]. It should be noted however that these
mechanisms do not act exclusively on DC migration, and often
exhibit pleotropic effects. This led us to examine two independent
experimental systems. One system is based on FTY720, which
desensitizes the S1P receptor, and thereby inhibits lymphocyte
migration [30]. The other system is based on BW254C, a
prostaglandin D1 analogue which interacts with the cognate DP1
receptor to inhibition of DC migration [5,42]. Choosing these two
effectors allowed us to use a drug that hampers positive migration
signals, as well as an agonist that activates a physiological
migration-impairing signal.
In spite of the major difference in their mode of action,
treatment with either FTY720 or BW245C at the early stages of
infection resulted in similar effects, impairment of both RTDC
recruitment and LVS colonization of the MdLN (Figure 8 and
Figure 9). Interestingly, the effect of FTY720 treatment on RTDC
migration-impairment was more pronounced than that of
BW245C (Compare Figure 8A and 8B and Figure 9A). This was
translated into a more effective inhibition of bacterial dissemina-
tion by FTY720 than by BW245C (Compare Figure 8D and
Figure 9B), providing additional support to the linkage between
RTDC and LVS trafficking.
Instillation of each one of the migration-impairing agents to
airways of infected mice prolonged disease progression. We chose,
however, to concentrate on BW254C which is a drug of short-
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therefore could influence later stages of disease. Instillation of the
BW254C on days 0 and 1 of infection delayed the onset of
morbidity by two days, and delayed the time of death by one day
(Figure 9C and 9D). This again argues for a DC-driven bacterial
spreading.
Taken together, all the observations presented here suggest that
F. tularensis can inhabit DC in vivo, and DC migration can play a
role in enhancing the invasiveness of the pathogen. In addition,
this study provides guidelines to the development of a novel
potential therapeutic strategy against respiratory tularemia. A
treatment, based on impairment of DC trafficking could delay the
onset of disease and provide an adequate window for the
identification and the application of a suitable antibiotic treatment.
Materials and Methods
Bacteria preparation
Francisella tularensis live vaccine strain (ATCC 29684) stocks were
plated on GCHI agar (GC Medium base, Difco, supplemented
with 1% hemoglobin and 1% Iso-Vitalex BD, France). Working
stocks were prepared from single individual colonies exhibiting the
large-light phenotype [57].
For cell and animal infection experiments, bacteria were grown
at 37uC to mid log phase (optical density of 0.1–0.2 at 660 nm) in
TSBC (TSB Difco, supplemented with 0.1% cysteine) in a
gyrostatory shaker. Bacteria were washed and then re-suspended
at the desired concentration in either PBS for animal infection
experiments, or RPMI 1640 medium (see below), devoid of
antibiotics, for cell infection experiments.
Killed bacterial suspension were generated by incubating
growth cultures, overnight, at room temperature in the presence
of 0.4% formaldehyde, followed by extensive washing with PBS.
Eukaryotic cell cultivation
BMDC were generated essentially according to the method
developed by Lutz et al. [58] as described in detail previously [34].
More than 95% of the cells were CD11c positive as assessed by
flow cytometry, indicating effective differentiation into DC.
BMDC as well as the J774A.1 macrophage–like cells were grown
in RPMI 1640 medium supplemented with 10% FCS, 2 mM L-
glutamine, 1 mM sodium pyruvate, 1% v/v MEM-EAGLE non-
essential amino acid solution, 100 U/ml penicillin, 100 mg/ml
streptomycin and 50 mM b-mercaptoethanol; all these components
were supplied by Biological Industries (Beit Haemek, Israel).
Cell Infection
BMDC (10
6 cells/well in 24 well plates in supplemented RPMI
devoid of antibiotics) were infected by pulsing with bacteria at an
MOI (multiplicity of infection) of 200. Infection was initiated by
spinning (140 g, 5 min) bacteria onto plated cells (this is referred to
as time point 0 of infection). Pulsed cells were incubated at 37uC,
5%CO2 for 1 h before adding gentamicin (Sigma) at a concentra-
tion of 2 mg/ml. Incubation was then continued for additional
23 hours prior to analysis. In an alternative protocol, gentamicin-
containing medium was replaced by fresh gentamicin-free medium
after 2 hrs. This had no effect on bacteria counting. It should be
pointed out that extracellular LVS did not propagate in the
eukaryotic-cell growth medium, as noted by others as well [13,59].
In vitro transmigration assay
Infected cells were resuspended in RPMI containing 1% FCS to
a concentration of 10
7 cells/ml and were placed (10
6 cells/well) in
the upper compartments of Transwell migration chambers (Costar
3421, Corning, NY). CCL19 (R&D Systems) diluted to concen-
trations of 200 ng/ml in RPMI+1% FCS was placed in the lower
compartments to induce CCR7-dependent chemotaxis. Medium
alone served to evaluate CCR7-independent migration. DC were
allowed to migrate through a polycarbonate (5 mm pore size mesh)
at 37uC for 2 h, and cells migrating to the lower compartment
were counted under light microscope. The experiments were
performed in triplicates and migration was determined by
calculating the percentage of migrating cells relative to input.
Lipopolysaccharide (LPS) pulsing was conducted by application of
1 mg/ml of Escherichia coli LPS (Sigma).
Animal infection and isolation of cells
C57BL female mice (8–10 weeks old) were used in most
infection experiments. Some experiments were repeated using
BALB/c mice as indicated. Mice anesthetized with ketamine/
xylazine were infected intranasally by careful application of 25 ml
LVS suspension at the desired concentration.
Bronchoalveolar lavages were performed on anesthetized mice
through a 23-gauge catheter inserted into the trachea. Doses of
1 ml cold PBS were infused into each mouse and then aspirated
from the airways. Animals were sacrificed by cervical dislocation
and the desired organs were collected. Isolated organs were
minced and treated with Liberase Blendzyme 3 (Roche) at final
concentration of 2 mg/ml for 30–60 minutes at 37uC, followed by
five minute treatment with 100 U/ml of Dnase I (Boehringer
Mannheim). This was followed by passage through a cell strainer
to obtain single cell suspension.
All experiments reported here were conducted in compliance
with the guidelines of the animal use committee at the Israel
Institute for Biological Research and are in accordance with the
Animal Welfare Act.
FTY720 and BW245C administration
FTY720 and BW245C were both purchased from Cayman
chemicals (Ann Arbor, MI). FTY720 was diluted to a concentra-
tion of 40 mg/ml in PBS containing 10% ethanol. Twenty-five ml
of the FTY720 solution (final amount of 1 mg) were administered
to anesthetized mice by intranasal instillation at day zero (15 min
prior to bacterial infection)
BW245C was diluted to a concentration of 0.4 mM in 0.3%
DMSO in water, immediately prior to use. Twenty-five ml of the
agonist solution (final amount of 10 nmol) were administered to
anesthetized mice by intranasal instillation on day zero and on day
1 post infection. Carriers alone were distillated into mock treated
animals
Enumeration of cell-associated bacteria
Infected cell suspensions were submitted to centrifugation
(140 g, 10 min), followed by two washes with PBS, in order to
remove non-associated bacteria. When indicated, cells were
incubated at 37uC for 30 min in the presence of 20 mg/ml
gentamicin, followed by centrifugation and washes for gentamicin
removal. Cells were lysed with either 0.1% deoxycholate (DOC)
for 2 minutes or alternatively with 0.1% saponin for 30 minutes at
37uC. Bacterial suspensions were submitted to intensive mixing
prior to serial dilution and plating on GCHI agar.
Flow cytometry
Washed DC were incubated with PE or APC conjugated
antibodies against CD11c (Clone N418), CD11b (clone M1/70),
CD40 (clone 1C10), CD83 (clone Mitchel-17) and CD86 (clone
GL1), as well as with the appropriate isotype-matched control
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CA). Staining was performed using standard incubation protocols
(30 min at 4uC) except for CCR7 staining which was conducted at
37uC as indicated by the manufacturer. In all staining protocols, FcR
was blocked prior to staining with FCR Block Reagent (Miltenyi
Biotech, Germany), according to the manufacturer’s protocol. Cells
were collected on a FACSCalibur cytometry (Becton & Dickinson),
excluding events smaller than 200 on the FSC.
Magnetic cell sorting
Target cells were separated from the lymph node single cell
suspension by magnetic microbeads carrying either anti-CD11c or
anti CD11b antibodies (Miltenyi Biotech,
Germany), using the manufacturer’s instructions. Prior to
separation, cell suspensions were treated with the FcR Block
Reagent (see above). About 10
8 cells (pool of 8–10 lymph nodes)
were then incubated with 100 ml of the microbead suspension for
15 min on ice, and washed to remove excess of free beads. Cells
were passed through a column attached to a magnet and washed
to separate bound and unbound cells. Out of 10
8 cells submitted to
sorting, about 10
6 cells were bound to either anti-CD11c or anti-
CD11b microbeads
Monitoring in vivo migration of airway cells
Migration of cells from the airways to the peripheral lymph
node was evaluated by tracking cells labeled by viable staining
[29,34]. Briefly, the orange cell tracer CMTMR (Molecular
Probes, OR) was diluted in RPMI to a concentration of 8 mM and
30 ml/mouse were administered intranasally to mice anesthetized
with ketamine/xylazine. Five hours later mice were instilled with
5610
6 bacteria per mouse (25 ml of bacterial suspension in PBS).
At the indicated time post addition of bacteria, MdLNs were
isolated, shredded and treated with 2 mg/ml Collagenase-D
(Roche) for 30 min at 37uC. Cells were then passed through a
70 mm nylon mesh to yield a single-cell suspension, and analyzed
by FACS.
In situ visualization of cell-associated bacteria
Tissues or cells infected by LVS were examined for the presence
of bacteria by fluorescent staining. J774A.1 cells were cultivated
and infected in chamber slides and fixed with 3.7% formaldehyde.
DC suspensions derived from bone marrow or from lymph nodes
were placed in LabTekII chambered glass slides which are capable
of binding semi-adherent cells (Nunc, Roskilde, Denmark). Cells
were incubated for 20 minute at 37uC to allow binding. The
bound cells were fixed with 3.7% formaldehyde in PBS for
30 min, followed by washing with PBS.
Dissected MdLNs were infiltrated with OCT (Sakura, The
Netherlands), snap frozen in liquid nitrogen and transferred to
storage at 270uC. Eight-micrometer cryostatic sections were cut
and mounted on SuperFrost Plus slides (Menzel-Galaser, Ger-
many). Slides were then fixed by dipping in cold acetone (220uC)
for 1 min. Fixed slides were blocked with either 0.5% BSA in PBS
in the case of infected cell preparations, or with Rodent Block M
(Biocare Medical, CA), for infected tissue. Hyper-immune
antiserum of rabbits immunized with formalin killed LVS diluted
1/300 served as primary antibody, while normal rabbit serum
served as negative control. Texas-Red or FITC-conjugated goat
anti rabbit antibodies (Molecular Probes, OR) served as second
antibody. Stained specimen were examined with an Axiovert 200
inverted microscope (Zeiss) equipped with an AxioCAM MRc5
digital camera (Zeiss).
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